malignant glioma

Showing 26 - 50 of 124

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Malignant Glioma Trial in United States (PVSRIPO)

Active, not recruiting
  • Malignant Glioma
  • PVSRIPO
  • San Francisco, California
  • +5 more
Jun 28, 2022

Malignant Glioma, Glioblastoma Trial in Durham (hEGFRvIII-CD3 (BRiTE), Activated Cell Therapy)

Not yet recruiting
  • Malignant Glioma
  • Glioblastoma
  • hEGFRvIII-CD3 (BRiTE)
  • Activated Cell Therapy
  • Durham, North Carolina
    Duke University Medical Center
Jun 24, 2022

Supratentorial Tumors, Malignant, Malignant Glioma, Glioblastoma Trial in Birmingham, Columbus (G207)

Active, not recruiting
  • Supratentorial Neoplasms, Malignant
  • +6 more
  • G207
  • Birmingham, Alabama
  • +1 more
Jun 1, 2022

Malignant Glioma, Recurrent Glioblastoma Trial in Chicago (biological, other, procedure)

Completed
  • Malignant Glioma
  • Recurrent Glioblastoma
  • Durvalumab
  • +3 more
  • Chicago, Illinois
    Northwestern University
Mar 17, 2022

Malignant Glioma, Glioblastoma, Gliosarcoma Trial in Durham (Bevacizumab, Temozolomide, Radiation Therapy (XRT))

Completed
  • Malignant Glioma
  • +2 more
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke
Mar 29, 2022

Malignant Glioma Trial in Tampa, Columbus (Hypofractionated Stereotactic Irradiation, Nivolumab, Bevacizumab)

Active, not recruiting
  • Malignant Glioma
  • Hypofractionated Stereotactic Irradiation
  • +3 more
  • Tampa, Florida
  • +1 more
Mar 23, 2022

Malignant Glioma Trial in Durham (D2C7-IT (6920 ng/mL via convection-enhanced delivery), Atezolizumab (1200 mg every three

Recruiting
  • Malignant Glioma
  • D2C7-IT (6920 ng/mL via convection-enhanced delivery)
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Mar 22, 2022

Glioblastoma, Recurrent Adult Brain Tumor, Malignant Glioma Trial in Richmond (sorafenib tosylate, valproic acid, sildenafil

Active, not recruiting
  • Glioblastoma
  • +3 more
  • sorafenib tosylate
  • +2 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Mar 21, 2022

Glioma, Brain Tumor, Primary Brain Tumor Trial in Miami (3T MRI Scanner)

Recruiting
  • Glioma
  • +4 more
  • 3T MRI Scanner
  • Miami, Florida
    University of Miami
Mar 15, 2022

Malignant Glioma Trial in Nashville (Bevacizumab, Temozolomide, Vitamin C)

Completed
  • Malignant Glioma
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Mar 9, 2022

Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)

Completed
  • Advanced Solid Tumors
  • +6 more
  • Cabiralizumab
  • Nivolumab
  • Scottsdale, Arizona
  • +38 more
Jan 5, 2022

Glioblastoma, Astrocytoma, Grade III, Astrocytoma, Grade IV Trial in Lake Success (Stereotactic Radiosurgery)

Active, not recruiting
  • Glioblastoma
  • +3 more
  • Stereotactic Radiosurgery
  • Lake Success, New York
    Northwell Health Brain Tumor Center
Feb 3, 2022

Malignant Glioma Trial in Germany (IDH1R132H peptide vaccine, Avelumab)

Recruiting
  • Malignant Glioma
  • Berlin, Germany
  • +9 more
Feb 1, 2022

Glioblastoma Multiforme, Glioblastoma, Malignant Glioma Trial in Gainesville, Orlando, Durham (pp65-shLAMP DC with GM-CSF,

Recruiting
  • Glioblastoma Multiforme
  • +4 more
  • pp65-shLAMP DC with GM-CSF
  • +4 more
  • Gainesville, Florida
  • +2 more
Jan 6, 2022

Recurrent Medulloblastoma, Recurrent Brain Tumor, Childhood, Malignant Glioma Trial in Durham (PEP-CMV)

Recruiting
  • Recurrent Medulloblastoma
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Jan 8, 2022

Malignant Glioma Trial in Paris (Surgery, radiotherapy)

Completed
  • Malignant Glioma
  • Surgery
  • radiotherapy
  • Paris, France
    Florence Laigle
Nov 26, 2021

Intractable Epilepsy, Malignant Glioma, Seizure Disorder Trial in Jacksonville (Anticonvulsant Agent, Perampanel,

Recruiting
  • Intractable Epilepsy
  • +2 more
  • Anticonvulsant Agent
  • +3 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Nov 22, 2021

Glioblastoma, Low Grade Glioma, Malignant Glioma Trial in Houston (Mind-Body Intervention Procedure, Quality-of-Life Assessment,

Completed
  • Glioblastoma
  • +5 more
  • Mind-Body Intervention Procedure
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 8, 2021

Malignant Glioma, Recurrent Ependymoma Trial in Chicago, Boston (biological, drug, radiation)

Completed
  • Malignant Glioma
  • Recurrent Ependymoma
  • AdV-tk
  • +2 more
  • Chicago, Illinois
  • +1 more
Oct 26, 2021

Glioma, Malignant Glioma, Recurrent Glioma Trial in Los Angeles (Biospecimen Collection, Diagnostic Imaging, Magnetic Resonance

Recruiting
  • Glioma
  • +3 more
  • Biospecimen Collection
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 24, 2021

Malignant Glioma, Glioblastoma Multiforme Trial in Ann Arbor (Dose Escalation of Ad-hCMV-TK and Ad-hCMV-Flt3L)

Completed
  • Malignant Glioma
  • Glioblastoma Multiforme
  • Dose Escalation of Ad-hCMV-TK and Ad-hCMV-Flt3L
  • Ann Arbor, Michigan
    University of Michigan Health System Department of Neurosurgery
Aug 25, 2021

Malignant Brain Tumor, Malignant Glioma Trial in Palo Alto (procedure, biological, drug, device)

Suspended
  • Malignant Brain Neoplasm
  • Malignant Glioma
  • Near-Infrared Fluorescence Imaging
  • +3 more
  • Palo Alto, California
    Stanford University School of Medicine
Aug 10, 2021

Malignant Glioma, Recurrent Glioma Trial in Beijing (personalized vaccine)

Recruiting
  • Malignant Glioma
  • Recurrent Glioma
  • personalized vaccine
  • Beijing, Beijing, China
    Xuanwu Hospital, Capital Medical University
Jun 26, 2021

Quality of Life of Glioblastoma Treated With Tumor-Treating

Completed
  • Malignant Glioma
  • NovoTTF
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke
Jun 7, 2021

Glioblastoma, Malignant Glioma Trial in Canada, Switzerland, United States (drug, radiation, device)

Completed
  • Glioblastoma
  • Malignant Glioma
  • La Jolla, California
  • +7 more
Apr 13, 2021